These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15047743)

  • 21. Follow-up with histopathology and HPV testing on LSIL cytology in China's largest academic woman's hospital.
    Tao X; Zhang H; Zhang H; Xiao J; Li J; Zhou X; Wang L; Zhao C
    Cancer Cytopathol; 2019 Apr; 127(4):258-266. PubMed ID: 30892831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive diagnostic values and histological detection ratios from the Rotterdam cervical cancer screening programme.
    Kreuger FA; Beerman H; Nijs HG; van Ballegooijen M
    Int J Epidemiol; 1998 Jun; 27(3):377-81. PubMed ID: 9698123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome analysis of 4 years' follow-up of patients referred for colposcopy with one smear showing mild dyskaryosis.
    Ahmed AS; Goumalatsos G; Akbar N; Lawton FG; Savvas M
    Cytopathology; 2008 Apr; 19(2):94-105. PubMed ID: 17937774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial.
    TOMBOLA Group
    BMJ; 2009 Jul; 339():b2546. PubMed ID: 19638646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomised healthcare policy evaluation of organised primary human papillomavirus screening of women aged 56-60.
    Lamin H; Eklund C; Elfström KM; Carlsten-Thor A; Hortlund M; Elfgren K; Törnberg S; Dillner J
    BMJ Open; 2017 May; 7(5):e014788. PubMed ID: 28566363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
    Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
    BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
    Zorzi M; Del Mistro A; Farruggio A; de'Bartolomeis L; Frayle-Salamanca H; Baboci L; Bertazzo A; Cocco P; Fedato C; Gennaro M; Marchi N; Penon MG; Cogo C; Ferro A
    BJOG; 2013 Sep; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytological changes preceding cervical cancer.
    Robertson JH; Woodend B; Elliott H
    J Clin Pathol; 1994 Mar; 47(3):278-9. PubMed ID: 8093150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+ detection rates.
    Rozemeijer K; Penning C; Siebers AG; Naber SK; Matthijsse SM; van Ballegooijen M; van Kemenade FJ; de Kok IM
    Cancer Causes Control; 2016 Jan; 27(1):15-25. PubMed ID: 26458884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
    Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical importance of "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion (LSIL-H)" terminology for cervical smears 5-year analysis of the positive predictive value of LSIL-H compared with ASC-H, LSIL, and HSIL in the detection of high-grade cervical lesions with a review of the literature.
    Ince U; Aydin O; Peker O
    Gynecol Oncol; 2011 Apr; 121(1):152-6. PubMed ID: 21211831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of cervical precancer among HPV-negative women in the Netherlands and its association with previous HPV and cytology results: A follow-up analysis of a randomized screening study.
    Inturrisi F; Rozendaal L; Veldhuijzen NJ; Heideman DAM; Meijer CJLM; Berkhof J
    PLoS Med; 2022 Oct; 19(10):e1004115. PubMed ID: 36306283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cervical intraepithelial neoplasia grade III (CIN III) and invasive cervical carcinoma: the yawning gap revisited and the treatment of risk.
    Herbert A; Smith JA
    Cytopathology; 1999 Jun; 10(3):161-70. PubMed ID: 10390064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia.
    Liao SY; Stanbridge EJ
    Cancer; 2000 Mar; 88(5):1108-21. PubMed ID: 10699902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interlaboratory reproducibility of liquid-based equivocal cervical cytology within a randomized controlled trial framework.
    Confortini M; Bondi A; Cariaggi MP; Carozzi F; Dalla Palma P; Ghiringhello B; Minucci D; Montanari G; Parisio F; Prandi S; Schiboni ML; Ronco G
    Diagn Cytopathol; 2007 Sep; 35(9):541-4. PubMed ID: 17703457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia.
    Arbyn M; Buntinx F; Van Ranst M; Paraskevaidis E; Martin-Hirsch P; Dillner J
    J Natl Cancer Inst; 2004 Feb; 96(4):280-93. PubMed ID: 14970277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expanded cytological referral criteria for colposcopy in cervical screening: comparison with human papillomavirus testing.
    Paraskevaidis E; Malamou-Mitsi V; Koliopoulos G; Pappa L; Lolis E; Georgiou I; Agnantis NJ
    Gynecol Oncol; 2001 Aug; 82(2):355-9. PubMed ID: 11531293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
    Wu Y; Zhao J; Hu J; Wu XW; Zhu LR
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267
    [No Abstract]   [Full Text] [Related]  

  • 39. Cervical glandular neoplasia referrals and the diagnosis of adenocarcinoma in situ: Correlating cytology, colposcopy findings, and clinical outcomes.
    Nikolopoulos M; Athanasias P; Godfrey MAL; Nikolopoulos K; Maheshwari MK
    Cytopathology; 2021 Nov; 32(6):751-757. PubMed ID: 34181788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.